VIRUSLI GEPATIT: EPIDEMIOLOGIYA, DIAGNOSTIKA VA DAVOLASH
Keywords:
Kalit so'zlar: virusli gepatit, hepatit A, hepatit B, hepatit C, epidemiologiya, diagnostika, antiviral terapiya, profilaktika, jigar sirrozi.Abstract
ANNOTATSIYA
Virusli gepatit — jigar to'qimasining turli viruslar (HAV, HBV, HCV, HDV,
HEV) tomonidan keltirib chiqariladigan yallig'lanish kasalligidir. Ushbu maqolada
virusli gepatitning epidemiologik tarqalishi, patogenetik mexanizmlari, zamonaviy
diagnostika usullari va davolash yondashuvlari IMRAD tizimida tizimli tarzda ko'rib
chiqiladi. Jahon sog'liqni saqlash tashkiloti (JSST) ma'lumotlariga ko'ra, dunyo bo'ylab
354 million kishi surunkali B va C gepatit bilan kasallangan. O'zbekistonda
epidemiologik vaziyat ham chuqur tahlilni talab qiladi. Maqolada laboratoriya va
instrumental diagnostika usullari, antiviral terapiya protokollari va profilaktika
choralari batafsil bayon etilgan. Olingan natijalar shuni ko'rsatadiki, erta diagnostika
va o'z vaqtida boshlangan kompleks davolash kasallik asoratlarini sezilarli darajada
kamaytiradi.
References
ADABIYOTLAR
1. World Health Organization. (2023). Global Hepatitis Report 2024. Geneva:
WHO Press.
2. Polaris Observatory HCV Collaborators. (2022). Global prevalence and
genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet
Gastroenterology & Hepatology, 2(3), 161–176.
3. Lozano R., et al. (2020). Global and regional mortality from 235 causes of
death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden
of Disease Study. The Lancet, 380(9859), 2095–2128.
4. Terrault N.A., et al. (2018). AASLD Guidelines for Treatment of Chronic
Hepatitis B. Hepatology, 67(4), 1560–1599.
5. European Association for the Study of the Liver (EASL). (2020). EASL
Recommendations on Treatment of Hepatitis C: Final Update of the Series. Journal of
Hepatology, 73(5), 1170–1218.
6. McMahon B.J. (2019). Natural history of chronic hepatitis B — clinical
implications. Medscape Journal of Medicine, 10(5), 91.
7. Yuen M.F., et al. (2018). Hepatitis B virus infection. Nature Reviews Disease
Primers, 4, 18035.
8. Lampertico P., et al. (2017). EASL 2017 Clinical Practice Guidelines on the
management of hepatitis B virus infection. Journal of Hepatology, 67(2), 370–398.
9. Schillie S., et al. (2020). Prevention of Hepatitis B Virus Infection in the
United States. MMWR Recommendations and Reports, 67(1), 1–31.
10. Sulkowski M.S., et al. (2019). Daclatasvir plus sofosbuvir for previously
treated or untreated chronic HCV infection. New England Journal of Medicine, 370(3),
211–221.
11. Karimov Sh.I., Xudoyberdiyev D.K. (2022). O'zbekistonda virusli gepatit B
epidemiologiyasi: zamonaviy holat va profilaktika. O'zbekiston tibbiyot jurnali, 6, 45–
52.
12. Razzoqov A.A. (2021). Surunkali gepatit C ning zamonaviy davolash
protokollari. Tibbiyot va sog'liqni saqlash, 3, 18–24.
13. Mirzayev B.T., Nazarova G.R. (2023). Virusli gepatit B va D koinfeksiyasi:
klinik xususiyatlar va davolash natijalari. Infeksion kasalliklar, 2,31- 38
